CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 983 enrolled
Drug / intervention
Coronary angioplastydevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03893396
NCT03893396N/ACompleted
CompareCT.gov

Safety Assessment of Angioplasty Procedures

Groupe Hospitalier de la Rochelle Ré Aunis·observational·Posted Mar 28, 2019·Updated Sep 19, 2024

In Brief

An observational study evaluating Coronary angioplasty for Angiospastic; Disorder. Completed, enrolled 983 participants across 1 site.

Detailed Summary

Ischemic heart disease, or coronary heart disease, covers a set of pathologies due to insufficient oxygen supply to the myocardium due to the development of atherosclerosis in one or more coronary arteries. To evaluate the safety of angioplasty performed in patients operated on at La Rochelle Hospital, the rate of major adverse cardiac events (MACE) will be determined and compared with data from the literature.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAngiospastic; Disorder
CountriesFrance
CollaboratorsBBraun Medical SAS

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedMar 28, 2019
Enrollment StartApr 1, 2019
Primary CompletionMar 30, 2021
Study CompletionApr 30, 2023
TodayJul 2, 2026
Enrollment to primary: 2.0 yearsPosted 7.3 years ago

Interventions

Coronary angioplastydevice

Procedure used to open clogged heart arteries. Involves the insertion of a tiny balloon and/or a stent to widen the artery.